Patents/Assignees

MAPI PHARMA Ltd.

7 patents in portfolio

US12370233utility2025
Depot Systems Comprising Glatiramer Acetate
0 cites
US12343371utility2025
Method for Suppressing or Alleviating Primary or Secondary Progressive Multiple Sclerosis (PPMS or SPMS) Using a Sustained Release Depot Formulation Comprising Glatiramer Acetate
0 cites
US12251380utility2025
Depot Systems Comprising Cariprazine or Salts Thereof
0 cites
USRE050301reissue2025
Depot Systems Comprising Glatiramer or Pharmacologically Acceptable Salt Thereof
0 cites
US12097292utility2024
Process for Preparing Microparticles Containing Glatiramer Acetate
0 cites
US11931357utility2024
Depot Systems Comprising Cariprazine or Salts Thereof
0 cites
US11865213utility2024
Semaglutide Depot Systems and Use Thereof
0 cites